AU749059B2 - Therapeutic use of lentiviral vectors - Google Patents
Therapeutic use of lentiviral vectors Download PDFInfo
- Publication number
- AU749059B2 AU749059B2 AU18035/99A AU1803599A AU749059B2 AU 749059 B2 AU749059 B2 AU 749059B2 AU 18035/99 A AU18035/99 A AU 18035/99A AU 1803599 A AU1803599 A AU 1803599A AU 749059 B2 AU749059 B2 AU 749059B2
- Authority
- AU
- Australia
- Prior art keywords
- vector
- hiv
- cells
- lentivirus
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- AIDS & HIV (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6957997P | 1997-12-12 | 1997-12-12 | |
| US60/069579 | 1997-12-12 | ||
| PCT/US1998/025720 WO1999030742A1 (en) | 1997-12-12 | 1998-12-11 | Therapeutic use of lentiviral vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1803599A AU1803599A (en) | 1999-07-05 |
| AU749059B2 true AU749059B2 (en) | 2002-06-20 |
Family
ID=22089926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18035/99A Ceased AU749059B2 (en) | 1997-12-12 | 1998-12-11 | Therapeutic use of lentiviral vectors |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1037669A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002508338A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20010033062A (cg-RX-API-DMAC7.html) |
| AU (1) | AU749059B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2314683A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999030742A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2388301C (en) | 1999-10-22 | 2011-01-04 | Aventis Pasteur Limited | Modified gp100 and uses thereof |
| US6656706B2 (en) | 1999-12-23 | 2003-12-02 | The United States Of America As Represented By The Department Of Health And Human Services | Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
| US7851212B2 (en) | 2000-05-10 | 2010-12-14 | Sanofi Pasteur Limited | Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
| US6712612B1 (en) | 2000-12-12 | 2004-03-30 | Genecure Llc | Safe and stable retroviral helper cell line and related compositions and methods |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| WO2004094642A2 (en) | 2003-04-24 | 2004-11-04 | Fondazione Centro San Raffaele Del Monte Tabor | Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
| WO2009049350A1 (en) | 2007-10-15 | 2009-04-23 | The University Of Queensland | Expression system for modulating an immune response |
| US9795658B2 (en) | 2010-04-20 | 2017-10-24 | Admedus Vaccines Pty Ltd | Expression system for modulating an immune response |
| CN108601951B (zh) | 2015-12-09 | 2022-11-22 | 金港医疗(澳大利亚)私人有限公司 | 用于治疗的免疫调节组合物 |
| US11285191B2 (en) | 2016-07-26 | 2022-03-29 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Immunostimulatory compositions and uses therefor |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5650309A (en) * | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0816507A4 (en) * | 1995-03-16 | 1998-07-01 | Hisamitsu Pharmaceutical Co | NEW RECOMBINANT GEN |
| US6013516A (en) * | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| WO1997020052A1 (en) * | 1995-11-28 | 1997-06-05 | Clinical Technologies, Inc. | Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
| ATE455858T1 (de) * | 1995-11-28 | 2010-02-15 | Univ Johns Hopkins Med | Konditionell replizierende virale vektoren und ihre verwendung |
| AP964A (en) * | 1996-02-21 | 2001-05-11 | Julianna Lisziewicz | Methods and compositions for protective and therapeutic genetic immunisation. |
| CA2247091A1 (en) * | 1996-03-05 | 1997-09-12 | The Regents Of The University Of California | Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| WO1998003669A2 (en) * | 1996-07-22 | 1998-01-29 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Vectors for inhibiting hiv and tumor growth |
| JP2001513643A (ja) * | 1997-03-06 | 2001-09-04 | ウーベルラ、クラウス | レンチウイルスをベースとするベクター及びベクター系 |
| GB9704977D0 (en) * | 1997-03-11 | 1997-04-30 | Univ Glasgow | FIV vaccine |
| EP1003894A2 (en) * | 1997-07-18 | 2000-05-31 | Chiron Corporation | Lentiviral vectors |
-
1998
- 1998-12-11 JP JP2000538720A patent/JP2002508338A/ja active Pending
- 1998-12-11 WO PCT/US1998/025720 patent/WO1999030742A1/en not_active Ceased
- 1998-12-11 KR KR1020007006423A patent/KR20010033062A/ko not_active Withdrawn
- 1998-12-11 EP EP98962895A patent/EP1037669A4/en not_active Withdrawn
- 1998-12-11 CA CA002314683A patent/CA2314683A1/en not_active Abandoned
- 1998-12-11 AU AU18035/99A patent/AU749059B2/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5650309A (en) * | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010033062A (ko) | 2001-04-25 |
| CA2314683A1 (en) | 1999-06-24 |
| EP1037669A4 (en) | 2003-04-02 |
| EP1037669A1 (en) | 2000-09-27 |
| WO1999030742A1 (en) | 1999-06-24 |
| JP2002508338A (ja) | 2002-03-19 |
| AU1803599A (en) | 1999-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4190579B2 (ja) | 非分裂細胞への核酸運搬のためのベクターおよび使用方法 | |
| US5635399A (en) | Retroviral vectors expressing cytokines | |
| US6428953B1 (en) | Method and means for producing high titer, safe, recombinant lentivirus vectors | |
| US11279949B2 (en) | Recombinant vectors comprising 2A peptide | |
| JP4390860B2 (ja) | レンチウイルスをベースにした遺伝子転移ベクター | |
| CA2328404C (en) | Novel lentiviral packaging cells | |
| JPH10507905A (ja) | ヒト血清による溶解耐性生産者細胞系で生産されるレトロウイルスベクター | |
| CA2314683A1 (en) | Therapeutic use of lentiviral vectors | |
| EP0970201A1 (en) | Retroviral vectors capable of transducing non-dividing cells | |
| US6130089A (en) | Materials and methods for gene transfer | |
| CA2233867C (en) | Vector and method of use for nucleic acid delivery to non-dividing cells | |
| AU758600B2 (en) | Vector and method of use for nucleic acid delivery to non-dividing cells | |
| WO1999019496A1 (en) | Inhibition of human immunodeficiency virus (hiv-1) replication |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: CELL GENESYS, INC. Free format text: THE FORMER OWNER WAS: LUIGI NALDINI, JIN-PING SONG |
|
| FGA | Letters patent sealed or granted (standard patent) |